The clinical use of HVPG measurements in chronic liver disease (Q37590666)

21 August 2017

1 reference

title

The clinical use of HVPG measurements in chronic liver disease (English)

1 reference

21 August 2017

main subject

chronic liver disease

0 references

Juan G Abraldes

2

0 references

Juan Carlos García-Pagan

object named as

Juan Carlos García-Pagan

series ordinal

4

0 references

Jaime Bosch

series ordinal

1

object named as

Jaime Bosch

1 reference

21 August 2017

3

Annalisa Berzigotti

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

21 August 2017

published in

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

573-582

1 reference

Diagnosis and monitoring of portal hypertension.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Portal pressure, presence of gastroesophageal varices and variceal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

The hepatic venous pressure gradient: anything worth doing should be done right

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Measurement of portal pressure and its role in the management of chronic liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Portal hypertension and gastrointestinal bleeding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Non invasive diagnosis of portal hypertension in cirrhotic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Portal vein thrombosis in adults: pathophysiology, pathogenesis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatology may have problems with putative surrogate outcome measures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

East meets the West--portal pressure predicts outcome of surgical resection for hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Prognostic indicators in alcoholic cirrhotic men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Current management of portal hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Prognostic value of early measurements of portal pressure in acute variceal bleeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Prevention of variceal rebleeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2009.149

Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding

31 March 2020

1 reference

12 December 2020

Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test

1 reference

12 December 2020

Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices

1 reference

12 December 2020

Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis

1 reference

12 December 2020

10.1038/NRGASTRO.2009.149

Identifiers

DOI

1 reference

21 August 2017

1 reference